These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7512473)

  • 1. Hypertension and insulin resistance. Glycaemia and insulinaemia in overweight hypertensive patients.
    Weichenhain B; van Kooten HJ; Standl E
    Drugs; 1993; 46 Suppl 2():183-8. PubMed ID: 7512473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulinaemia and slight overweight: the case of Vietnamese hypertensives.
    Van Minh H; Thanh LC; Thi BN; do Trinh T; Tho TD; Valensi P
    Int J Obes Relat Metab Disord; 1997 Oct; 21(10):897-902. PubMed ID: 9347408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance and beta-cell hypersecretion in essential hypertension.
    Sechi LA; Tedde R; Marigliano A; Melis A; Pala A; Orecchioni C
    J Hypertens Suppl; 1990 Sep; 8(4):S87-9. PubMed ID: 2258791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between insulin suppression test and quantitative insulin sensitivity check index in hypertensive and normotensive obese patients.
    González-Albarrán O; García-Robles R
    Diabetes Care; 2001 Nov; 24(11):1998-2000. PubMed ID: 11679472
    [No Abstract]   [Full Text] [Related]  

  • 5. The pathogenesis of hypertension in obese subjects.
    Weidmann P; de Courten M; Boehlen L; Shaw S
    Drugs; 1993; 46 Suppl 2():197-208; discussion 208-9. PubMed ID: 7512475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between hyperinsulinemia and ambulatory blood pressure monitoring of lean and overweight male hypertensives.
    Feldstein CA; Renauld A; Akopian M; Olivieri AO; Garrido D
    J Cardiovasc Risk; 1998 Feb; 5(1):25-30. PubMed ID: 9816552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical assessment of metabolic effects of antihypertensive therapy].
    Tkacheva ON; Shumbutova AIu; Novikova IM; Samsonenko NS; Guseva KIu
    Kardiologiia; 2008; 48(3):34-8. PubMed ID: 18429754
    [No Abstract]   [Full Text] [Related]  

  • 8. Blood pressure, insulin secretion and resistance in nonhypertensive and hypertensive obese female subjects.
    Sinagra D; Greco D; Scarpitta AM; Bonaventura V
    Int J Obes Relat Metab Disord; 1995 Sep; 19(9):610-3. PubMed ID: 8574270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective imidazoline agonist moxonidine plus the ACE inhibitor ramipril in hypertensive patients with impaired insulin sensitivity: partners in a successful MARRIAGE?
    Rayner B
    Curr Med Res Opin; 2004 Mar; 20(3):359-67. PubMed ID: 15025845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Behavior of C-peptide, insulin and glucose levels in blood during conditions of evaluating selected antihypertensive drugs in patients with hypertension and non-insulin-dependent diabetes (type 2)].
    Jasik M; Kasperska-Dworak A; Czyzyk A
    Pol Arch Med Wewn; 1993 Jun; 89(6):445-55. PubMed ID: 8415207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology and treatment of the obesity-related arterial hypertension.
    Kolanowski J
    Acta Clin Belg Suppl; 1992; 14():18-25. PubMed ID: 1604957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.
    Chapman MJ; Sposito AC
    Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance and essential hypertension: pathophysiologic and therapeutic implications.
    Santucci A; Ferri C
    J Hypertens Suppl; 1992 Apr; 10(2):S9-15. PubMed ID: 1593308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A preliminary study of insulin resistance in essential hypertension, simple obesity and acromegaly].
    Zhao D
    Zhonghua Xin Xue Guan Bing Za Zhi; 1993 Oct; 21(5):269-71, 314. PubMed ID: 8200305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nitrendipine on glucose tolerance and serum insulin and dehydroepiandrosterone sulfate levels in insulin-resistant obese and hypertensive men.
    Beer NA; Jakubowicz DJ; Beer RM; Arocha IR; Nestler JE
    J Clin Endocrinol Metab; 1993 Jan; 76(1):178-83. PubMed ID: 8421087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypertension in obese patients: Pathophysiology and management].
    Girerd X; Hansel B
    Presse Med; 2009 Apr; 38(4):609-13. PubMed ID: 19233604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are metabolic syndrome and its components in obese children influenced by the overweight status or the insulin resistance?
    Zachurzok-Buczyńska A; Klimek K; Firek-Pedras M; Małecka-Tendera E
    Endokrynol Pol; 2011; 62(2):102-8. PubMed ID: 21528471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of insulin resistance in essential hypertension.
    Lind L; Berne C; Lithell H
    J Hypertens; 1995 Dec; 13(12 Pt 1):1457-62. PubMed ID: 8866908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system.
    Scheen AJ
    Drugs; 2004; 64(22):2537-65. PubMed ID: 15516153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of olmesartan vs irbesartan on metabolic parameters and visfatin in hypertensive obese women.
    De Luis DA; Conde R; Gonzalez Sagrado M; Aller R; Izaola O; Perez Castrillon JL; Romero E; Castro MJ
    Eur Rev Med Pharmacol Sci; 2010 Sep; 14(9):759-63. PubMed ID: 21061834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.